These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3148261

  • 1. Studies on the effect of long-term use of low dose aspirin in Kawasaki disease.
    Hamasaki Y, Ichimaru T, Tasaki H, Miyazaki S.
    Acta Paediatr Jpn; 1988 Feb; 30(1):63-7. PubMed ID: 3148261
    [No Abstract] [Full Text] [Related]

  • 2. Prostacyclin, thromboxane and prostaglandin F2 alpha in suction blister fluid of human skin: effect of systemic aspirin and local glucocorticosteroid treatment.
    Oikarinen A, Viinikka L, Rytsälä H, Kiistala U, Ylikorkala O.
    Life Sci; 1981 Jul 27; 29(4):391-6. PubMed ID: 7024698
    [No Abstract] [Full Text] [Related]

  • 3. Relative insensitivity of epinephrine induced platelet aggregation to prostacyclin.
    Zahavi M, Zahavi J.
    Thromb Res; 1986 Oct 01; 44(1):119-24. PubMed ID: 3538494
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dosage frequency for suppression of platelet function by low dose aspirin therapy.
    Bradlow BA, Chetty N.
    Thromb Res; 1982 Jul 01; 27(1):99-110. PubMed ID: 7123514
    [Abstract] [Full Text] [Related]

  • 6. Long-term ultra-low-dose aspirin therapy and platelet function.
    Chetty N, Atkinson PM, Bradlow BA.
    S Afr Med J; 1985 Aug 31; 68(5):307-9. PubMed ID: 3929399
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.
    Cornelissen J, Kirtland S, Lim E, Goddard M, Bellm S, Sheridan K, Large S, Vuylsteke A.
    Thromb Haemost; 2006 Mar 31; 95(3):476-82. PubMed ID: 16525576
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 10. EG-626: not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation.
    Tanaka K, Harada Y, Katori M.
    Prostaglandins; 1979 Feb 26; 17(2):235-7. PubMed ID: 375319
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
    Gentry PA, Niemuller C, Ross ML, Liptrap RM.
    Comp Biochem Physiol A Comp Physiol; 1989 Feb 26; 94(1):47-51. PubMed ID: 2571453
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent.
    De Caterina R, Giannessi D, Gazzetti P, Bernini W.
    Thromb Res; 1985 Jan 15; 37(2):337-42. PubMed ID: 3975876
    [No Abstract] [Full Text] [Related]

  • 14. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
    Balduini CL, Bertolino G, Noris P, Sinigaglia F, Bisio A, Torti M.
    Biochem Biophys Res Commun; 1988 Oct 31; 156(2):823-9. PubMed ID: 3190682
    [Abstract] [Full Text] [Related]

  • 15. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
    Willerson JT, Campbell WB, Winniford MD, Schmitz J, Apprill P, Firth BG, Ashton J, Smitherman T, Bush L, Buja LM.
    Am J Cardiol; 1984 Dec 01; 54(10):1349-54. PubMed ID: 6391133
    [No Abstract] [Full Text] [Related]

  • 16. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W, Roth P, Weber PC.
    Thromb Haemost; 1981 Jun 30; 45(3):204-7. PubMed ID: 7025338
    [Abstract] [Full Text] [Related]

  • 17. Effect of aspirin infusions on platelet function in humans.
    Wilson KM, Siebert DM, Duncan EM, Somogyi AA, Lloyd JV, Bochner F.
    Clin Sci (Lond); 1990 Jul 30; 79(1):37-42. PubMed ID: 2167788
    [Abstract] [Full Text] [Related]

  • 18. Prospective Evaluation of Genetic Variation in Platelet Endothelial Aggregation Receptor 1 Reveals Aspirin-Dependent Effects on Platelet Aggregation Pathways.
    Backman JD, Yerges-Armstrong LM, Horenstein RB, Newcomer S, Shaub S, Morrisey M, Donnelly P, Drolet M, Tanner K, Pavlovich MA, O'Connell JR, Mitchell BD, Lewis JP.
    Clin Transl Sci; 2017 Mar 30; 10(2):102-109. PubMed ID: 28075528
    [Abstract] [Full Text] [Related]

  • 19. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG.
    Adv Prostaglandin Thromboxane Res; 1980 Mar 30; 6():317-20. PubMed ID: 6992529
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and metabolism of prostaglandins, prostacyclin, and thromboxanes: the arachidonic acid cascade.
    Ramwell PW, Foegh M, Loeb R, Leovey EM.
    Semin Perinatol; 1980 Jan 30; 4(1):3-13. PubMed ID: 6247764
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.